Screening method for nonsteroidal antiinflammatory drugs based on the cyclooxygenase 2 pathway activated by serum-free stimulation in A549 cells

Yakugaku Zasshi

Volumn 127, Issue 3, 2007, Pages 527-532

  Yao, Jin Cheng ^a   Duan, Wei Gang ^a   Yun, Yu ^b   Liu, De Quan ^b   Yan, Ming ^a   Jiang, Zhen Zhou ^a   Zhang, Lu Yong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

A549; Drug screening; Enzyme immunoassay; Nonsteroidal antiinflammatory drugs; Prostaglandin E2

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ARTICLE; CELL STIMULATION; CELL STRAIN; CELL STRAIN A549; CONTROLLED STUDY; DRUG SCREENING; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CULTURE MEDIA, SERUM-FREE; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HUMANS; IMMUNOENZYME TECHNIQUES; NITROBENZENES; PYRAZOLES; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 33847627130     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.527     Document Type: Article

References (33)

1. Kis B., Snipes J. A., Busija D. W., J. Pharmacol. Exp. Ther., 315, 1-7 (2005).
2. Cui J. G., Kuroda H., Chandrasekharan N. V., Pelaez R. P., Simmons D. L., Bazan N. G., Neurochem. Res., 29, 1731-1737 (2004).
3. Mitchell J. A., Akarasereenont P., Thiemermann C., Flower R. J., Vane J. R., Proc. Natl. Acad. Sci. U.S.A., 90, 11693-11697 (1993).
4. Wu S., Duan S., Zhao S., Cai Y., Chen P., Fang X., Respir. Res., 6, 27 (2005).
5. Chang M., Chen B. C., Yu M. T., Sheu J. R., Chen T. F., Lin C. H., Cell. Signal., 17, 299-310 (2005).
6. Jung Y. J., Isaacs J. S., Lee S., Trepel J., Neckers L., FASEB J., 17, 2115-2117 (2003).
7. Masferrer J. L., Zweifel B. S., Manning P. T., Hauser S. D., Leahy K. M., Smith W. G., Proc. Natl. Acad. Sci. U.S.A., 91, 3228-3232 (1994).
8. Taketo M. M., J. Natl. Cancer Inst., 90, 1529-1536 (1998).
9. Yamada T., Komoto J., Watanabe K., Ohmiya Y., Takusagawa F., J. Mol. Biol., 348, 1163-1176 (2005).
10. Han R., Tsui S., Smith T. J., J. Biol. Chem., 277, 16355-16364 (2002).
11. Williams G. W., Curr. Pain Headache Rep., 9, 377-389 (2005).
12. Borer J. S., Simon L. S., Arthritis Res. Ther., 7 (Suppl 4), S14-22 (2005).
13. Han S. Y., Lee N. K., Kim K. H., Jang I.W., Yim M., Kim J. H., Blood, 106, 1240-1245 (2005).
14. Barnett J., Chow J., Ives D., Chiou M., Mackenzie R., Osen E., Nguyen B., Tsing S., Bach C., Freire J., Biochim. Biophys. Acta, 1209, 130-139 (1994).
15. Smith C. J., Zhang Y., Koboldt C. M., Muhammad J., Zweifel B. S., Shaffer A., Talley J. J., Masferrer J. L., Seibert K., Isakson P. C., Proc. Natl. Acad. Sci. U.S.A., 95, 13313-13318 (1998).
16. Johnson J. L., Wimsatt J., Buckel S. D., Dyer R. D., Maddipati K. R., Arch. Biochem. Biophys., 324, 26-34 (1995).
17. Duan W., Zhang L., Prostaglandins Leukot. Essent Fatty Acids, 74, 317-321 (2006).
18. Zhang J. H., Chung T. D. Y., Oldenburg K. R., J. Biomol. Screening, 4, 67-73 (1999).
19. Abelson M. B., Butrus S. I., Kliman G. H., Larson D. L., Corey E. J., Smith L. M., J. Ocul. Pharmacol., 3, 63-75 (1987).
20. Crummey A., Harper G. P., Boyle E. A., Mangan F. R., Agents Actions, 20, 69-76 (1987).
21. Brooks R. R., Carpenter J. F., Jones S. M., Ziegler T. C., Pong S. F., J. Pharmacol. Methods, 25, 275-283 (1991).
22. Lees P., Delatour P., Foster A. P., Foot R., Baggot D., Br. Vet. J., 152, 199-211 (1996).
23. Michaluart P., Masferrer J. L., Carothers A. M., Subbaramaiah K., Zweifel B. S., Koboldt C., Cancer Res., 59, 2347-2352 (1999).
24. Huss U., Ringbom T., Perera P., Bohlin L., Vasange M., J. Nat. Prod., 65, 1517-1521 (2002).
25. Baurin N., Mozziconacci J. C., Arnoult E., Chavatte P., Marot C., Morin-Allory L., J. Chem. Inf. Comput. Sci., 44, 276-285 (2004).
26. Rollinger J. M., Haupt S., Stuppner H., Langer T., J. Chem. Inf. Comput. Sci., 44, 480-488 (2004).
27. Kulmacz R. J., Lands W. E., Prostaglandins, 25, 531-540 (1983).
28. Shitashige M., Morita I., Murota S., Biochim. Biophys. Acta, 1389, 57-66 (1998).
29. Wang Z., Xie C., Zhang J., Sun J., Zhou J., Wang M., Zhong Guo Yao Xue Za Zhi, 38, 2006-2008 (2003).
30. Hu Y. F., Cheng G. F., Yao Xue Xue Bao, 35, 343-346 (2000).
31. Asano K., Lilly C. M., Drazen J. M., Am. J. Physiol., 271(1Pt1), L126-131 (1996).
32. Iwakubo M., Okada Y., Kawata T., Odai H., Takahashi N., Shindo K., Kimura K., Tagami Y., Miyake M., Fukushima K., Inagaki M., Amano M., Kaibuchi K., Iijima H., Bioorg. Med. Chem., 12, 2115-2137 (2004).
33. Duan W. G., Sun L. X., Liu J., Wu X. D., Zhang L. Y., Yan M., Biol. Pharm. Bull., 29, 1138-1142 (2006).